Trials investigating the role of ICIs in RCC patients demonstrated a >1% PD-L1 expression ranging from 24% in the CheckMate-214 study (57) to 63.2% in the JAVELIN Renal 101 study (13). The gene discussed is CD274; the disease is renal cell carcinoma.